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A B S T R A C T
Leigh Syndrome is a neurodegenerative disorder caused by mitochondrial dysfunction, with significant phe-
notypic and genetic heterogeneity. It usually presents in early life, with a severe prognosis. It can be caused by
more than 75 different gene mutations, of nuclear and mitochondrial origin, involving all respiratory chain
complexes, with less than 25% of Leigh syndrome having mitochondrial DNA mutations. The typical pathologic
hallmarks are focal, bilateral, and symmetric lesions in the basal ganglia, thalamus, cerebellum, cerebral white
matter and spinal cord gray matter, usually with T2WI and FLAIR hyperintensity. The basal ganglia and thalami
frequently present with a pattern of cytotoxic edema. We present one case with clinical and analytical features
consistent with Leigh Syndrome, with peculiar imaging features, showing dominant cerebellar edematous
changes with unexpected petechial component suggestive of microangiopathy. To our knowledge, these features
are unreported and suggest the existence of microvascular lesions. Based on the reported imaging findings, we
propose that Leigh Syndrome should be added to the differential diagnosis of acute cerebellitis.
1. Background
Leigh Syndrome (or subacute necrotizing encephalomyelopathy) is
a mitochondrial neurodegenerative disorder, with a significant pheno-
typic and genetic heterogeneity. Usually presenting in infancy or early
childhood, it has a severe prognosis [1], being relatively common, with
an incidence of 1 in 40,000 births and no known predilection for sex or
race [2].
Leigh syndrome can be caused by more than 75 different gene
mutations, of both nuclear and mitochondrial origin, involving all re-
spiratory chain complexes [2,3]. With current genetic diagnostic tech-
nology, both nuclear and mitochondrial gene mutations are being
identified at an increasing rate [1]. Less than 25% of affected in-
dividuals have mitochondrial DNA (mtDNA) mutations [1].
Signs and symptoms usually appear between 3 and 12months of
age, but the age of onset is variable, with evidence of connatal disease
in some patients and adult-onset presentation in others [4,5]. Once the
clinical signs appear, the disease often results in regression of both
mental and motor skills, leading to disability and progression to death
[1,5]. There is a wide range of possible initial manifestations of the
disease. Gait disturbance, hypotonia, dystonia, dysarthria, intellectual
regression, dysphagia and gastrointestinal distress are some of the most
common signs and symptoms at presentation [1,5]. Refractory seizures,
dystonic posturing, encephalopathy, and ataxia are usually seen later in
the disease evolution [ 1]. The most frequent cause of death is re-
spiratory failure [1].
The symptoms may have variable progression, but early-onset pa-
tients generally have a worse prognosis. Most patients die within a few
years of diagnosis, being 2.4 years the median age of death after first
symptoms [4]. This variability can be related to the genetic mutation
effect and the frequency of stressors, such as intercurrent illnesses.
The typical pathologic hallmarks are focal, bilateral, and symmetric
spongiform lesions in the thalamus, putamen, periaqueductal gray
matter, pons, medulla oblongata, inferior olives, and posterior columns
of the spinal cord [6].
On MRI, T2WI and FLAIR usually show bilateral and symmetrical
hyperintensities in basal ganglia, thalami, cerebellum, cerebral white
matter and spinal cord gray matter [6]. Although basal ganglia lesions
are most typical, their magnitude and extent are quite variable [7].
Cerebellar white matter lesions are less prominent and usually occur
when supratentorial white matter lesions are already visible [8]. Al-
though rare, there are reported cases with notable cerebellar affection
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Fig. 1. Symmetric partial superior vermis and cerebellum hemispheric affection, including cortex and white matter. Displayed images show central areas of T1 hypo
and hyperintensity (A), and gadolinium enhancement (B); T2 (C) and T2 FLAIR (D) wider hyperintensity; T2* (E,F) shows peripheric hypointensity foci related to
blood degradation products; (G,H) DWI and ADC map show features of peripheric restricted diffusion; (I) Symmetric lenticular anterior-inferior T2 hyperintensity
(similar findings on follow-up exam). There was no evidence of the typical restricted diffusion on the basal ganglia (DWI and ADC map not shown).
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[9]. Evidence of cytotoxic edema, with a pattern of restricted diffusion,
is frequently present in basal ganglia and thalami [10]. Spectroscopy
usually shows a lactate peak and a decrease in NAA [10].
2. Case presentation
Our patient was born to nonconsanguineous parents, with an un-
eventful personal and family medical history. Manifestations of neu-
rological illness were first recognized at two years of age, when poor
language skills, motor incoordination and frequent falls were noticed.
The boy was evaluated in our neurology clinic 2 years later, with de-
velopmental regression and additional neurological signs, including
muscular hypotrophy, orofacial dyskinesia, dysarthria and bilateral
Babinski sign. Muscle tone and strength were normal. At this point,
serum lactate and alanine were slightly elevated. Organic acid chro-
matography and MRI were normal. During the following year, there
was a progressive worsening of motor function with chorea, ataxia and
kinetic tremor.
At the age of 8, neurologic symptoms aggravated in the context of
febrile illness and he was admitted for additional investigation and
treatment. CSF lactate was abnormal (3,6mmol/L; reference value:
1,1–2,4 mmol/L) and lactate blood levels varied between slightly ele-
vated and normal (0,8–2,9mmol/L). CSF cell count, glucose and
protein were within reference values. Multiplex PCR in CSF for viral
agents (Enterovirus, Coxsackievirus, Poliovirus, Herpes simplex 1 and
2, Herpes hominis 6 and 7, Cytomegalovirus, Epstein Barr virus,
Varicella zoster virus) was negative. Brain MRI revealed cerebellar
edema with peripheral petechial hemorrhages, gadolinium enhance-
ment and restricted diffusion (Fig. 1 A-H). A bilateral T2 hyperintensity
(Fig. 1 I) was seen in the lenticular nuclei and tectum. A muscle biopsy
was performed, and genetic testing revealed an m.8993 T > C mis-
sense mutation on the MT-ATP6 gene, with heteroplasmy of 98%,
consistent with Leigh Syndrome.
Pyruvate, blood glucose, hepatic and renal function, creatine kinase,
ammonia, repeated amino acids, organic acids, homocysteine, biotini-
dase activity, chitotriosidase activity and pyruvate dehydrogenase
complex activity were all normal.
Six months later, in the context of a febrile illness, there was an
acute and severe neurologic deterioration. A new brain MRI (Fig. 2)
showed a symmetric hyperintense signal in the cerebellar cortex and
white matter with hemorrhagic cortical component and intense gado-
linium enhancement. Hypointense foci on SWI remained on the pre-
viously affected regions and developed on the currently edematous
area. Spectroscopy showed a prominent lactate peak. The lenticular T2
hyperintensities were similar to the previous MRI and there was, in
addition, a loss of supratentorial white matter volume.
Fig. 2. On the second MRI, the previously non-affected part of the cerebellum showed (A) cortical T1 spontaneous hyperintensity and (B) gadolinium enhancement;
as well as cortical and subcortical edematous changes, with (C) T2 and (D) T2 FLAIR hyperintensity. SWI shows hypointense foci on the previous (E) and currently
affected regions (F). (G) Short TE Spectroscopy with left cerebellar hemisphere voxel, shows evident NAA reduction, as well as choline, lactate peaks.
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3. Discussion
Lax et al described ischemic-like lesions in the cerebellar cortex in
8/16 patients with mitochondrial disease, although none had Leigh
Syndrome [11]. These lesions were suggestive of dysfunction of vas-
cular smooth muscle cells and blood–brain barrier breakdown [11].
Other reports provide further evidence in favor of cerebral micro-
angiopathy in mitochondrial diseases, mainly in MELAS (mitochondrial
myopathy, encephalopathy, lactic acidosis and stroke-like episodes),
MERRF (myoclonic epilepsy with ragged-red fibers) and LHON (Leber
hereditary optic neuropathy) [12–14].
Our patient had progressive ataxia, extrapyramidal signs, variable
serum lactate and high CSF lactate with genetic confirmation of Leigh
syndrome. Two episodes of increasingly severe ataxia, fever and cere-
bellar lesion could be compatible with cerebellitis. However, the re-
current symptoms, normal CSF examination and negative multiplex
PCR testing would argue against this diagnosis and are consistent with
mitochondrial disease.
The relationship between cerebral microbleeds and vasculopathy is
established in the literature [15,16]. The cerebellar lesions with con-
trast enhancement, T1 spontaneous hyperintensity and SWI hy-
pointensity as petechial hemorrhages, were suggestive of microangio-
pathy. We propose that they may result from mitochondrial
microangiopathy.
In the follow-up brain MRI, six months later, there were substantial
changes within the cerebellum. The T2 hyperintense, edematous lesions
showed similar features on both exams but topographically changed.
The edematous area of the second MRI was almost a mirror-image of
the previously affected area (compare Figs. 1C-D with 2 C-D).
Another unusual feature was the isolated involvement of cerebellar
white matter without supratentorial white matter lesions. Nonetheless,
a loss of supratentorial white matter volume was apparent. Cystic
components or gliotic changes were absent, which is also atypical [17].
A prominent basal ganglia T2 hyperintensity, paradigmatic for
Leigh syndrome, was not seen in this patient although this has been
previously reported [6].
In conclusion, we present a Leigh syndrome-like patient with ima-
ging features not previously published and eventually resulting from
microangiopathy. Additionally, we propose that Leigh Syndrome
should be added to the differential diagnosis of acute cerebellitis.
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